 |
 |
 |
 |
|
 |
Previous 25 Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Efficacy and Safety of AP 12009 (trabedersen) in Patients With Recurrent or Refractory Anaplastic Astrocytoma (SAPPHIRE) |
 |
Lucknow, India Mumbai, India Thiruvananthapuram, India Guadalajara, Mexico Mexico City, Mexico Mexico City, Mexico Bydgoszcz, Poland Gdansk, Poland Lódz, Poland Lublin, Poland Sosnowiec, Poland Moscow, Russian Federation Samara, Russian Federation St. Petersburg, Russian Federation St. Petersburg, Russian Federation Baracaldo, Spain Barcelona, Spain Madrid, Spain Santander, Spain Edinburgh, UK London, UK |
 |
08/31/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas
|
 |
La Jolla, CA |
 |
08/17/2010 |
 |
 |
 |
Details |
 |
Study of XL184 in Adults With Glioblastoma Multiforme |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC Rochester, NY |
 |
07/18/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
 |
Rochester, NY |
 |
04/13/2010 |
 |
 |
 |
Details |
 |
Phase I Study To Test The Safety of TVAX Immunotherapy As A Treatment For Recurrent Grade III/IV Gliomas |
 |
Lenexa, KS |
 |
04/12/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors |
 |
San Francisco, CA |
 |
04/12/2010 |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
03/31/2010 |
 |
 |
 |
 |
 |
Details |
 |
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
 |
Houston, TX |
 |
03/30/2010 |
 |
 |
 |
Details |
 |
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
 |
Houston, TX |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
 |
San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
 |
Duarte, CA Chicago, IL Columbus, OH San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
 |
Los Angeles, CA Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas |
 |
Cincinnati, OH |
 |
01/03/2010 |
 |
 |
 |
Details |
 |
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
 |
Boston, MA |
 |
09/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC |
 |
09/05/2009 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
 |
 |